W. Zilly
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Antibiotics Pharmacokinetics and Efficacy
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders
Papers in
- Pharmacology 15
- Drug-Induced Hepatotoxicity and Protection 10
- Pharmacogenetics and Drug Metabolism 7
- Hepatology 10
- Liver Disease and Transplantation 6
- Co-authors
- Erik A. RichterD. D. BreimerD.D. BreimerU. ArmbrechtHartwig KlinkerErnst RichterR. StockbrüggerN. Rietbrock
- Journals
- Clinical Pharmacology & Therapeutics (6 papers)European Journal of Clinical Pharmacology (3 papers)Journal of Molecular Medicine (2 papers)European Journal of Gastroenterology & Hepatology (1 paper)Disability and Rehabilitation (1 paper)
- Partner nations
- GermanyNetherlandsAustria
In The Last Decade
W. Zilly
41 papers receiving 614 citations
Peers
Comparison fields: 5 of 80
- Pharmacology 290
- Clinical Biochemistry 56
- Hepatology 63
- Pharmacology 115
- Oncology 184
Countries citing papers authored by W. Zilly
This map shows the geographic impact of W. Zilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Zilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Zilly more than expected).
Fields of papers citing papers by W. Zilly
This network shows the impact of papers produced by W. Zilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Zilly. The network helps show where W. Zilly may publish in the future.
Co-authorship network
The 25 scholars most cited alongside W. Zilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 2 | |
| 2 | 1999 | 31 | |
| 3 | 1997 | 12 | |
| 4 | 1997 | 29 | |
| 5 | 1996 | 37 | |
| 6 | [Lidocaine elimination and MEGX formation after oral lidocaine administration--a practicable test for assessment of quantitative liver function]. | 1993 | 1 |
| 7 | Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology. | 1993 | 1 |
| 8 | [Drug clearance as a decision aid for further invasive liver diagnosis--studies with hexobarbital as a model substrate]. | 1992 | 1 |
| 9 | 1988 | 74 | |
| 10 | 1988 | 3 | |
| 11 | 1981 | 15 | |
| 12 | Pharmacokinetics and metabolism of theophylline in patients with liver diseases. | 1980 | 36 |
| 13 | [Fiberendoscopic injection therapy of bleeding gastrointestinal lesions (author's transl)]. | 1979 | 1 |
| 14 | [Studies on drug metabolism in obese men and mice (author's transl)]. | 1979 | 1 |
| 15 | Alternative transport pathways of cholephilic 14C-hexobarbital metabolites in rats with experimental hepatitis and cholestasis. | 1979 | 1 |
| 16 | [Pharmacokinetics of digoxin and methyldigoxin in patients with acute hepatitis (author's transl)]. | 1978 | 1 |
| 17 | [Metabolism of hexobarbital in patients with acute hepatitis and cirrhosis (author's transl)]. | 1977 | 4 |
| 18 | 1977 | 47 | |
| 19 | [Drug metabolism in experimental cholestasis]. | 1972 | 2 |
| 20 | [Barbiturate tolerance in patients with acute hepatitis]. | 1972 | 7 |
About W. Zilly
W. Zilly is a scholar working on Pharmacology, Hepatology, Clinical Biochemistry, Oncology and Pharmacology, having authored 42 papers that have together received 683 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (10 papers), Drug Transport and Resistance Mechanisms (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Pharmacogenetics and Drug Metabolism (7 papers), Liver Disease and Transplantation (6 papers), Metabolism and Genetic Disorders (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Diet and metabolism studies (3 papers). The work is most often cited by research in Pharmacology (290 citations), Clinical Biochemistry (56 citations), Hepatology (63 citations), Pharmacology (115 citations) and Oncology (184 citations). W. Zilly has collaborated with scholars based in Germany, Netherlands and Austria. Frequent co-authors include Erik A. Richter, D. D. Breimer, D.D. Breimer, U. Armbrecht, Hartwig Klinker, Ernst Richter, R. Stockbrügger, N. Rietbrock, Bernhard Schneider and J.M. van Rossum. Their work appears in journals such as Clinical Pharmacology & Therapeutics, European Journal of Clinical Pharmacology, Journal of Molecular Medicine, European Journal of Gastroenterology & Hepatology and Disability and Rehabilitation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.